Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act

Floor Speech

Date: Nov. 30, 2021
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. PALLONE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 3743) to increase funding for the Reagan-Udall Foundation for the Food and Drug Administration and for the Foundation for the National Institutes of Health.

The Clerk read the title of the bill.

The text of the bill is as follows: H.R. 3743

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE.

This Act may be cited as the ``Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act''. SEC. 2. REAGAN-UDALL FOUNDATION AND FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH.

(a) Reagan-Udall Foundation for the Food and Drug Administration.--Section 770(n) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379dd(n)) is amended by striking ``$500,000 and not more than $1,250,000'' and inserting ``$1,250,000 and not more than $5,000,000''.

(b) Foundation for the National Institutes of Health.-- Section 499(l) of the Public Health Service Act (42 U.S.C. 290b(l)) is amended by striking ``$500,000 and not more than $1,250,000'' and inserting ``$1,250,000 and not more than $5,000,000''.

BREAK IN TRANSCRIPT

Mr. PALLONE. 3743.

Mr. Speaker, I rise today in support of H.R. 3743, the Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act.

The Reagan-Udall Foundation for the FDA is an independent nonprofit organization established by Congress in 2007 to advance the mission of the FDA to modernize medical product development, accelerate innovation, and enhance safety.

Likewise, the Foundation for the NIH is an independent nonprofit organization established by Congress in 1990 to develop private-public partnerships that advance biomedical research, domestically and globally.

Both organizations work to advance the missions of the NIH and the FDA and have played important roles in our Nation's fight against COVID-19. For example, the Foundation for the NIH has worked to coordinate the ACTIV program that is strategizing our research and prioritizing and speeding development of the most promising COVID-19 vaccines and treatment. Likewise, the Reagan-Udall Foundation's COVID- 19 Diagnostics Evidence Accelerator has brought stakeholders together to collect and evaluate real-world data in a way that is scientifically useful and meets the FDA standards so we can understand the efficacy of COVID-19 diagnostics in the real world.

Mr. Speaker, the FDA and the NIH are currently authorized to transfer funding to their respective foundations within a statutory limit that has not been increased since 2007.

H.R. 3743 would increase the transfer authority for both foundations from up to $1.25 million to up to $5 million. This legislation will allow the agencies to increase their support consistent with the increasing costs of medical product research and development.

This bipartisan bill received unanimous support in the Energy and Commerce Committee. I would like to thank my colleagues, Representative Hudson and Health Subcommittee Chairwoman Eshoo, for their outstanding leadership on this legislation.

Mr. Speaker, I urge my colleagues to support H.R. 3743, and I reserve the balance of my time.
BREAK IN TRANSCRIPT

Mr. PALLONE. Mr. Speaker, I urge support for this bill, and I yield back the balance of my time.

BREAK IN TRANSCRIPT


Source
arrow_upward